www.rxcanadapharmacy.net
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Norfloxacin - Noroxin, Cellcept, Furadantin
Generic Noroxin
Norfloxacin (NORFLOXACIN) belongs to a class of drugs called quinolone antibiotics. Norfloxacin is used to treat a variety of bacterial infections
$0.89
Buy now!
Generic Cellcept
Mycophenolate mofetil 250/500mg
Generic CellCept is used for preventing organ rejection following kidney, liver or heart transplants. This medicine is used in combination with other medicines.
$8.44
Buy now!
Generic Furadantin
Generic Furadantin is used for treating and preventing urinary tract infections caused by certain bacteria.
$0.50
Buy now!
Choose Your language:
- Testimonials
-
I have used viagra before and tried your generic brand and is the same. Except yours cost a lot less. Am very happy and will buy again From softcock to hardcock in 20 minutes what can be better than that ! - thank you chris
Read more »
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Indians popping more antibiotics than ever: Study - Times of India
- Indians popping more antibiotics than ever: StudyTimes of IndiaPart B included drugs like Gentamicin, Amikacin, Pencillin, Oxacilin, Zolpidem, Cefalexin, Norfloxacin, Cefaclor and Cefdinir
- MP joins drug price chorus - Calcutta Telegraph
- MP joins drug price chorusCalcutta TelegraphAnother company has changed a combination of norfloxacin and metronidazole to a combination of ofloxacin and ornidazole (both are a combination of an antibiotic and an anti-protozoan agent) and raised the price from Rs 20 to Rs 79
- Fluoroquinolones May Increase Risk for Retinal Detachment, Study Finds - AAFP News Now
- Fluoroquinolones May Increase Risk for Retinal Detachment, Study FindsAAFP News NowCiprofloxacin contributed to the most cases of retinal detachment in the study, followed by levofloxacin and norfloxacin
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
